A Study of Radiation Dosimetry, Safety, and Tolerability of Extended Lutetium (177Lu) Vipivotide Tetraxetan Treatment in Chemo-naïve Adults With Metastatic Castration-resistant Prostate Cancer: RADIOpharmaceutical DOSimetry Evaluation (RADIODOSE) Study
Clinical trial NCT06531499 · RECRUITING
Trial details
- NCT number
- NCT06531499
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-11
- Primary completion
- 2028-11-24
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.